{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:19:00Z","timestamp":1787509140210,"version":"build-2736575974"},"reference-count":63,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2015,2,27]],"date-time":"2015-02-27T00:00:00Z","timestamp":1424995200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"the Chi Mei Medical Center, Tainan, Taiwan","award":["102CM-TMU-12"],"award-info":[{"award-number":["102CM-TMU-12"]}]},{"DOI":"10.13039\/501100004663","name":"The Ministry of Science and Technology of Taiwan","doi-asserted-by":"crossref","award":["NSC 102-2320-B-038-047"],"award-info":[{"award-number":["NSC 102-2320-B-038-047"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bpspubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["British J Pharmacology"],"published-print":{"date-parts":[[2015,4]]},"abstract":"<jats:sec>\n                    <jats:title>Background and Purpose<\/jats:title>\n                    <jats:p>\n                      Hydroxamate derivatives have attracted considerable attention because of their broad pharmacological properties. Recent studies reported their potential use in the treatment of cardiovascular diseases, arthritis and infectious diseases. However, the mechanisms of the anti\u2010inflammatory effects of hydroxamate derivatives remain to be elucidated. In an effort to develop a novel pharmacological agent that could suppress abnormally activated macrophages, we investigated a novel aliphatic hydroxamate derivative,\n                      <jats:styled-content style=\"fixed-case\">WMJ<\/jats:styled-content>\n                      \u2010\n                      <jats:styled-content style=\"fixed-case\">S<\/jats:styled-content>\n                      \u2010001, and explored its anti\u2010inflammatory mechanisms.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Experimental Approach<\/jats:title>\n                    <jats:p>\n                      <jats:styled-content style=\"fixed-case\">RAW<\/jats:styled-content>\n                      264.7 macrophages were exposed to\n                      <jats:styled-content style=\"fixed-case\">LPS<\/jats:styled-content>\n                      in the absence or presence of\n                      <jats:styled-content style=\"fixed-case\">WMJ<\/jats:styled-content>\n                      \u2010\n                      <jats:styled-content style=\"fixed-case\">S<\/jats:styled-content>\n                      \u2010001.\n                      <jats:styled-content style=\"fixed-case\">COX<\/jats:styled-content>\n                      \u20102 expression and signalling molecules activated by\n                      <jats:styled-content style=\"fixed-case\">LPS<\/jats:styled-content>\n                      were assessed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key Results<\/jats:title>\n                    <jats:p>\n                      <jats:styled-content style=\"fixed-case\">LPS<\/jats:styled-content>\n                      \u2010induced\n                      <jats:styled-content style=\"fixed-case\">COX<\/jats:styled-content>\n                      \u20102 expression was suppressed by\n                      <jats:styled-content style=\"fixed-case\">WMJ<\/jats:styled-content>\n                      \u2010\n                      <jats:styled-content style=\"fixed-case\">S<\/jats:styled-content>\n                      \u2010001.\n                      <jats:styled-content style=\"fixed-case\">WMJ<\/jats:styled-content>\n                      \u2010\n                      <jats:styled-content style=\"fixed-case\">S<\/jats:styled-content>\n                      \u2010001 inhibited p38\n                      <jats:styled-content style=\"fixed-case\">MAPK<\/jats:styled-content>\n                      ,\n                      <jats:styled-content style=\"fixed-case\">NF<\/jats:styled-content>\n                      \u2010\u03ba\n                      <jats:styled-content style=\"fixed-case\">B<\/jats:styled-content>\n                      subunit p65 and\n                      <jats:styled-content style=\"fixed-case\">CCAAT<\/jats:styled-content>\n                      \/enhancer\u2010binding protein (\n                      <jats:styled-content style=\"fixed-case\">C<\/jats:styled-content>\n                      \/\n                      <jats:styled-content style=\"fixed-case\">EBP<\/jats:styled-content>\n                      )\u03b2 phosphorylation in cells exposed to\n                      <jats:styled-content style=\"fixed-case\">LPS<\/jats:styled-content>\n                      . Treatment of cells with a p38\n                      <jats:styled-content style=\"fixed-case\">MAPK<\/jats:styled-content>\n                      inhibitor (p38\n                      <jats:styled-content style=\"fixed-case\">MAPK<\/jats:styled-content>\n                      inhibitor\n                      <jats:styled-content style=\"fixed-case\">III<\/jats:styled-content>\n                      ) markedly inhibited\n                      <jats:styled-content style=\"fixed-case\">LPS<\/jats:styled-content>\n                      \u2010induced p65 and\n                      <jats:styled-content style=\"fixed-case\">C<\/jats:styled-content>\n                      \/\n                      <jats:styled-content style=\"fixed-case\">EBP<\/jats:styled-content>\n                      \u03b2 phosphorylation and\n                      <jats:styled-content style=\"fixed-case\">COX<\/jats:styled-content>\n                      \u20102 expression.\n                      <jats:styled-content style=\"fixed-case\">LPS<\/jats:styled-content>\n                      \u2010increased p65 and\n                      <jats:styled-content style=\"fixed-case\">C<\/jats:styled-content>\n                      \/\n                      <jats:styled-content style=\"fixed-case\">EBP<\/jats:styled-content>\n                      \u03b2 binding to the\n                      <jats:styled-content style=\"fixed-case\">COX<\/jats:styled-content>\n                      \u20102 promoter region was suppressed in the presence of\n                      <jats:styled-content style=\"fixed-case\">WMJ<\/jats:styled-content>\n                      \u2010\n                      <jats:styled-content style=\"fixed-case\">S<\/jats:styled-content>\n                      \u2010001. In addition,\n                      <jats:styled-content style=\"fixed-case\">WMJ<\/jats:styled-content>\n                      \u2010\n                      <jats:styled-content style=\"fixed-case\">S<\/jats:styled-content>\n                      \u2010001 suppression of p38\n                      <jats:styled-content style=\"fixed-case\">MAPK<\/jats:styled-content>\n                      , p65 and\n                      <jats:styled-content style=\"fixed-case\">C<\/jats:styled-content>\n                      \/\n                      <jats:styled-content style=\"fixed-case\">EBP<\/jats:styled-content>\n                      \u03b2 phosphorylation, and subsequent\n                      <jats:styled-content style=\"fixed-case\">COX<\/jats:styled-content>\n                      \u20102 expression were restored in cells transfected with a dominant\u2010negative (\n                      <jats:styled-content style=\"fixed-case\">DN<\/jats:styled-content>\n                      ) mutant of\n                      <jats:styled-content style=\"fixed-case\">MAPK<\/jats:styled-content>\n                      phosphatase\u20101 (\n                      <jats:styled-content style=\"fixed-case\">MKP<\/jats:styled-content>\n                      \u20101).\n                      <jats:styled-content style=\"fixed-case\">WMJ<\/jats:styled-content>\n                      \u2010\n                      <jats:styled-content style=\"fixed-case\">S<\/jats:styled-content>\n                      \u2010001 also caused an increase in\n                      <jats:styled-content style=\"fixed-case\">MKP<\/jats:styled-content>\n                      \u20101 activity in\n                      <jats:styled-content style=\"fixed-case\">RAW<\/jats:styled-content>\n                      264.7 macrophages.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Implications<\/jats:title>\n                    <jats:p>\n                      <jats:styled-content style=\"fixed-case\">WMJ<\/jats:styled-content>\n                      \u2010\n                      <jats:styled-content style=\"fixed-case\">S<\/jats:styled-content>\n                      \u2010001 may activate\n                      <jats:styled-content style=\"fixed-case\">MKP<\/jats:styled-content>\n                      \u20101, which then dephosphorylates p38\n                      <jats:styled-content style=\"fixed-case\">MAPK<\/jats:styled-content>\n                      , resulting in a decrease in p65 and\n                      <jats:styled-content style=\"fixed-case\">C<\/jats:styled-content>\n                      \/\n                      <jats:styled-content style=\"fixed-case\">EBP<\/jats:styled-content>\n                      \u03b2 binding to the\n                      <jats:styled-content style=\"fixed-case\">COX<\/jats:styled-content>\n                      \u20102 promoter region and\n                      <jats:styled-content style=\"fixed-case\">COX<\/jats:styled-content>\n                      \u20102 down\u2010regulation in\n                      <jats:styled-content style=\"fixed-case\">LPS<\/jats:styled-content>\n                      \u2010stimulated\n                      <jats:styled-content style=\"fixed-case\">RAW<\/jats:styled-content>\n                      264.7 macrophages. The present study suggests that\n                      <jats:styled-content style=\"fixed-case\">WMJ<\/jats:styled-content>\n                      \u2010\n                      <jats:styled-content style=\"fixed-case\">S<\/jats:styled-content>\n                      \u2010001 may be a potential drug candidate for alleviating\n                      <jats:styled-content style=\"fixed-case\">LPS<\/jats:styled-content>\n                      \u2010associated inflammatory diseases.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/bph.13040","type":"journal-article","created":{"date-parts":[[2014,12,19]],"date-time":"2014-12-19T01:47:55Z","timestamp":1418953675000},"page":"1894-1908","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["<scp>WMJ<\/scp>\n                    \u2010\n                    <scp>S<\/scp>\n                    \u2010001, a novel aliphatic hydroxamate derivative, exhibits anti\u2010inflammatory properties via\n                    <scp>MKP<\/scp>\n                    \u20101 in\n                    <scp>LPS<\/scp>\n                    \u2010stimulated\n                    <scp>RAW<\/scp>\n                    264.7 macrophages"],"prefix":"10.1111","volume":"172","author":[{"given":"Wei\u2010Chuan","family":"Chen","sequence":"first","affiliation":[{"name":"Graduate Institute of Medical Sciences Taipei Medical University  Taipei Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia\u2010Sheng","family":"Yen","sequence":"additional","affiliation":[{"name":"Department of General Surgery Chi\u2010Mei Medical Center  Tainan Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei\u2010Jan","family":"Huang","sequence":"additional","affiliation":[{"name":"Graduate Institute of Pharmacognosy Taipei Medical University  Taipei Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya\u2010Fen","family":"Hsu","sequence":"additional","affiliation":[{"name":"Division of General Surgery Department of Surgery Landseed Hospital  Taoyuan Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Ou","sequence":"additional","affiliation":[{"name":"Department of Medicine University of British Columbia  Vancouver BC Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming\u2010Jen","family":"Hsu","sequence":"additional","affiliation":[{"name":"Graduate Institute of Medical Sciences Taipei Medical University  Taipei Taiwan"},{"name":"Department of Pharmacology, School of Medicine College of Medicine Taipei Medical University  Taipei Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,2,27]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20060336"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.12451"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2009.07.031"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.2174\/13895575113139990007"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri1004"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00141.2007"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20071728"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/35065000"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1062374"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0510965103"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2014.02.004"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.03266"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.20.091301.131133"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pharmtox.45.120403.095825"},{"key":"e_1_2_10_16_1","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1096\/fj.02-1078fje","article-title":"Cyclooxygenase\u20102\u2010deficient mice are resistant to endotoxin\u2010induced inflammation and death","volume":"17","author":"Ejima K","year":"2003","journal-title":"FASEB J"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2003.12.008"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0804343"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-007-0069-0"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.8.5015"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2227"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1042\/BST0360543"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra021333"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.1009668"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2011.08.015"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10456-013-9386-1"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10456-013-9386-1"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2289"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.1013565"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0034283"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2011.08.026"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbapap.2005.08.017"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.11.8111"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1177"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.11.7497"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.22.22.7802-7811.2002"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri910"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/mc.20652"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2005.06.022"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00477.2005"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri2035"},{"key":"e_1_2_10_42_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M710137200"},{"key":"e_1_2_10_43_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.164.11.5564"},{"key":"e_1_2_10_44_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M203218200"},{"key":"e_1_2_10_45_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.6.2207"},{"key":"e_1_2_10_46_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkt1143"},{"key":"e_1_2_10_47_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1210392"},{"key":"e_1_2_10_48_1","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.110.207449"},{"key":"e_1_2_10_49_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm400902y"},{"key":"e_1_2_10_50_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI39054"},{"key":"e_1_2_10_51_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.3.1899"},{"key":"e_1_2_10_52_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.173.3.2011"},{"key":"e_1_2_10_53_1","doi-asserted-by":"publisher","DOI":"10.1002\/jlb.60.1.8"},{"key":"e_1_2_10_54_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0503891102"},{"key":"e_1_2_10_55_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2010.01126.x"},{"key":"e_1_2_10_56_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.109.157438"},{"key":"e_1_2_10_57_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-0312"},{"key":"e_1_2_10_58_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0024377"},{"key":"e_1_2_10_59_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1203286"},{"key":"e_1_2_10_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pupt.2012.05.003"},{"key":"e_1_2_10_61_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M207470200"},{"key":"e_1_2_10_62_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M501762200"},{"key":"e_1_2_10_63_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M411200200"},{"key":"e_1_2_10_64_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20051794"}],"container-title":["British Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbph.13040","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bph.13040","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T17:25:58Z","timestamp":1694625958000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/bph.13040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,27]]},"references-count":63,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["10.1111\/bph.13040"],"URL":"https:\/\/doi.org\/10.1111\/bph.13040","archive":["Portico"],"relation":{},"ISSN":["0007-1188","1476-5381"],"issn-type":[{"value":"0007-1188","type":"print"},{"value":"1476-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,27]]},"assertion":[{"value":"2014-11-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-11-28","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-02-27","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}